AkzoNobel stock faces UK merger hurdle over refinish coatings

Published on 11/13/2026 at 17:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

AkzoNobel stock faces a UK competition hurdle in its planned Axalta merger. The parties have until November 18 to offer a remedy.

UK review raises merger stakes

The CMA sees a realistic prospect of weaker competition in UK vehicle refinish coatings.
AkzoNobel and Axalta plan to address the concern with a divestment package.
The companies continue to target merger completion in early 2027.

AkzoNobel, NL0013267909, Illustration mit AI erstellt.

AkzoNobel faces a new regulatory test for its planned merger with Axalta after the UK Competition and Markets Authority said on November 11 that the transaction could substantially lessen competition in vehicle refinish coatings. The CMA gave the parties until November 18 to offer undertakings that address its concerns, according to its Phase 1 decision summary.

Competition concern centers on refinish coatings

The CMA said AkzoNobel and Axalta compete closely in the UK, offering similar products, technical support and extensive manufacturer and insurer approvals. Their combined supply share in vehicle refinish coatings would be 40 to 50 percent, making the merged company the clear UK market leader, the regulator said.

The authority concluded that remaining rivals might not offset the loss of competition, particularly in premium products. Customers could consequently face higher prices or reduced quality and support. The finding is a Phase 1 competition assessment, not a final decision that the merger will harm customers.

Remedy and completion remain in focus

AkzoNobel and Axalta intend to use the same remedy proposal offered to the European Commission. That package includes the divestment of AkzoNobel's European vehicle refinish coatings business, including its UK operations. The CMA did not identify equivalent significant concerns in thermosetting powder coatings, where it found that alternative suppliers and multi-sourcing provide stronger competitive constraints.

The companies continue to target completion in early 2027. If they do not offer an acceptable undertaking, or if the CMA rejects it at the Phase 1 standard, the transaction will move to an in-depth Phase 2 investigation.

AkzoNobel stock traded at 62.94 euros on Lang & Schwarz at 17:05 CET on Friday, November 13.